Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$1,000.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bristol-Myers Squibb Co close to selling diabetes partnership stake to AstraZeneca Plc-Reuters


Wednesday, 18 Dec 2013 07:24pm EST 

Bristol-Myers Squibb Co:According to the Wall Street Journal, Bristol-Myers is close to selling its stake in a diabetes partnership with AstraZeneca Plc to the British drugmaker in a deal valued at more than $3 billion-Reuters.Bristol spokeswoman Laura Hortas declined to comment on the reported deal. Officials at AstraZeneca did not immediately respond to requests for comment. 

Company Quote

4468.5
95.0 +2.17%
27 May 2015